Brief: Immunome's Covid-19 Cocktail Retains Neutralizing Activity Against Most Prevalent Omicron Subvariants* In U.S., Ba.4/5 And Ba.2.12.1

Immunome

06/07/2022 13:06

July 6 (Reuters) - Immunome Inc  IMNM.O :
    * IMMUNOME'S COVID-19 COCKTAIL RETAINS NEUTRALIZING ACTIVITY
AGAINST MOST PREVALENT OMICRON SUBVARIANTS* IN US, BA.4/5 AND
BA.2.12.1
    * IMMUNOME INC - IMM-BCP-01 NEUTRALIZED BA.4/.5 AND
BA.2.12.1
SUBVARIANTS IN PSEUDOVIRUS TESTING
    * IMMUNOME INC - IMM-BCP-01 CURRENTLY IN PHASE 1B CLINICAL
TESTING
WITH TOPLINE DATA EXPECTED IN 2H 2022
    * IMMUNOME INC - LOOK FORWARD TO ANNOUNCING TOPLINE DATA
FROM OUR
PHASE 1B CLINICAL STUDY IN SECOND HALF OF 2022

Source text for Eikon:  ID:nBwc54VPha 
Further company coverage:  IMNM.O